Literature DB >> 9734526

Survival and disability at 7-8 years of age in New Zealand infants less than 28 weeks gestation.

B A Darlow1, L J Horwood, N Mogridge, R S Clemett.   

Abstract

AIMS: To determine the survival and disability rates at 7-8 years in infants of less than 28 weeks gestation born in New Zealand in 1986 and admitted to a neonatal unit.
METHODS: In 1986, all infants with birthweight less than 1500 g and admitted to neonatal units were enrolled in a prospective audit of retinopathy of prematurity. Surviving infants, including the subset born at less than 28 weeks gestation, have been assessed at a home visit. Parents completed a comprehensive questionnaire and children underwent a visual assessment and were tested on the Wechsler Intelligence Scale for Children.
RESULTS: Of 126 liveborn infants less than 28 weeks gestation, 80 (64%) survived to 7-8 years. Sixty eight children (97% survivors resident in New Zealand) were assessed: 72% had no, and 86% no or only mild disability, 77% had some visual problem, with close to one-third having myopia, strabismus or requiring spectacles and 32% received Ministry of Education funded special needs assistance.
CONCLUSIONS: There have been few long-term follow-up studies of infants of less than 28 weeks gestation born in a defined geographical area. The outcome for New Zealand infants is comparable with that in other published data.

Entities:  

Mesh:

Year:  1998        PMID: 9734526

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based, national study.

Authors:  A E Cust; B A Darlow; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

2.  Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data.

Authors:  B A Darlow; A E Cust; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.